Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2010, Article ID 160386, 9 pages
http://dx.doi.org/10.1155/2010/160386
Review Article

Fertility Preservation for Cancer Patients: A Review

1Department of Obstetrics and Gynaecology, Basingstoke and North Hampshire NHS Trust, Basingstoke RG24 9NA, UK
2Department of Obstetrics and Gynaecology, Brighton and Sussex University Hospitals, Eastern Road, Brighton BN2 5BE, UK

Received 28 September 2009; Accepted 2 March 2010

Academic Editor: Howard D. Homesley

Copyright © 2010 Tosin Ajala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NHS National Institute for Clinical Excellence, Clinical Guideline 11. 2004.
  2. British Fertility Society, “A strategy for fertility services for survivors of childhood cancer,” Human Fertility, vol. 6, no. 2, pp. A1–A40, 2003. View at Google Scholar
  3. Y. Sonoda, N. R. Abu-Rustum, M. L. Gemignani et al., “A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?” Gynecologic Oncology, vol. 95, no. 3, pp. 534–538, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Plante, M.-C. Renaud, I. A. Hoskins, and M. Roy, “Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature,” Gynecologic Oncology, vol. 98, no. 1, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Brydoy, S. D. Fossa, O. Klepp et al., “Paternity following treatment for testicular cancer,” Journal of the National Cancer Institute, vol. 97, no. 21, pp. 1580–1588, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. A. Huddart, A. Norman, C. Moynihan et al., “Fertility, gonadal and sexual function in survivors of testicular cancer,” British Journal of Cancer, vol. 93, no. 2, pp. 200–207, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Howell and S. Shalet, “Gonadal damage from chemotherapy and radiotherapy,” Endocrinology and Metabolism Clinics of North America, vol. 27, no. 4, pp. 927–943, 1998. View at Google Scholar · View at Scopus
  8. R. L. Schilsky, B. J. Lewis, R. J. Sherins, and R. C. Young, “Gonadal dysfunction in patients receiving chemotherapy for cancer,” Annals of Internal Medicine, vol. 93, no. 1, pp. 109–114, 1980. View at Google Scholar · View at Scopus
  9. S. A. Rivkees and J. D. Crawford, “The relationship of gonadal activity and chemotherapy-induced gonadal damage,” Journal of the American Medical Association, vol. 259, no. 14, pp. 2123–2125, 1988. View at Google Scholar · View at Scopus
  10. H. P. Roeser, A. E. Stocks, and A. J. Smith, “Testicular damage due to cytotoxic drugs and recovery after cessation of therapy,” Australian and New Zealand Journal of Medicine, vol. 8, no. 3, pp. 250–254, 1978. View at Google Scholar · View at Scopus
  11. G. L. Warne, K. F. Fairley, J. B. Hobbs, and F. I. R. Martin, “Cyclophosphamide induced ovarian failure,” The New England Journal of Medicine, vol. 289, no. 22, pp. 1159–1162, 1973. View at Google Scholar · View at Scopus
  12. S. J. Richardson, V. Senikas, and J. F. Nelson, “Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion,” Journal of Clinical Endocrinology and Metabolism, vol. 65, no. 6, pp. 1231–1237, 1987. View at Google Scholar · View at Scopus
  13. G. J. Budgell, R. A. Cowan, and A. R. Hounsell, “Prediction of scattered dose to the testes in abdominopelvic radiotherapy,” Clinical Oncology, vol. 13, no. 2, pp. 120–125, 2001. View at Google Scholar · View at Scopus
  14. R. M. Hermann, K. Henkel, H. Christiansen et al., “Testicular dose and hormonal changes after radiotherapy of rectal cancer,” Radiotherapy and Oncology, vol. 75, no. 1, pp. 83–88, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. W. H. B. Wallace, A. B. Thomson, F. Saran, and T. W. Kelsey, “Predicting age of ovarian failure after radiation to a field that includes the ovaries,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 3, pp. 738–744, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. O. D. Critchley, W. H. B. Wallace, S. M. Shalet, H. Mamtora, J. Higginson, and D. C. Anderson, “Abdominal irradiation in childhood; the potential for pregnancy,” British Journal of Obstetrics and Gynaecology, vol. 99, no. 5, pp. 392–394, 1992. View at Google Scholar · View at Scopus
  17. H. O. Critchley and W. H. Wallace, “Impact of cancer treatment on uterine function,” Journal of the National Cancer Institute Monographs, no. 34, pp. 64–68, 2005. View at Google Scholar · View at Scopus
  18. E. C. Larsen, K. Schmiegelow, C. Rechnitzer, A. Loft, J. Müller, and A. N. Andersen, “Radiotherapy at a young age reduces uterine volume of childhood cancer survivors,” Acta Obstetricia et Gynecologica Scandinavica, vol. 83, no. 1, pp. 96–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-M. Liao, J. Doyle, N. S. Crouch, and S. M. Creighton, “Dilation as treatment for vaginal agenesis and hypoplasia: a pilot exploration of benefits and barriers as perceived by patients,” Journal of Obstetrics and Gynaecology, vol. 26, no. 2, pp. 144–148, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. N. Aass, S. D. Fossa, L. Theodorsen, and N. Norman, “Prediction of long-term gonadal toxicity after standard treatment for testicular cancer,” European Journal of Cancer, vol. 27, no. 9, pp. 1087–1091, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. Petersen, A. Giwercman, G. Daugaard et al., “Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis,” Journal of Clinical Oncology, vol. 20, no. 6, pp. 1537–1543, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Albers, W. Albrecht, F. Algaba et al., “Guidelines on testicular cancer,” European Urology, vol. 48, no. 6, pp. 885–894, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. L. Gandini, P. Sgrò, F. Lombardo et al., “Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients,” Human Reproduction, vol. 21, no. 11, pp. 2882–2889, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. M. Petersen, G. Daugaard, M. Rørth et al., “Endocrine function in patients treated for carcinoma in situ in the testis with irradiation,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 111, no. 1, pp. 93–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Basavaraju and C. E. Easterly, “Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications,” Medical Physics, vol. 29, no. 10, pp. 2391–2403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ataya, L. V. Rao, E. Lawrence, and R. Kimmel, “Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys,” Biology of Reproduction, vol. 52, no. 2, pp. 365–372, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Recchia, G. Sica, S. De Filippis, G. Saggio, M. Rosselli, and S. Rea, “Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study,” Anti-Cancer Drugs, vol. 13, no. 4, pp. 417–424, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Urruticoechea, M. Arnedos, G. Walsh, M. Dowsett, and I. E. Smith, “Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC),” Breast Cancer Research and Treatment, vol. 110, no. 3, pp. 411–416, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K.-G. Huang, C.-L. Lee, C.-S. Tsai, C.-M. Han, and L.-L. Hwang, “A new approach for laparoscopic ovarian transposition before pelvic irradiation,” Gynecologic Oncology, vol. 105, no. 1, pp. 234–237, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. F. M. Howard, “Laparoscopic lateral ovarian transposition before radiation treatment of hodgkin disease,” Journal of the American Association of Gynecologic Laparoscopists, vol. 4, no. 5, pp. 601–604, 1997. View at Google Scholar · View at Scopus
  31. L. L. Veeck, R. Bodine, R. N. Clarke et al., “High pregnancy rates can be achieved after freezing and thawing human blastocysts,” Fertility and Sterility, vol. 82, no. 5, pp. 1418–1427, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. T. S. Kosasa, P. I. McNamee, C. Morton et al., “Pregnancy rates after transfer of cryopreserved blastocysts cultured in a sequential media,” American Journal of Obstetrics and Gynecology, vol. 192, no. 6, pp. 2035–2040, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks, “Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation,” Journal of Clinical Oncology, vol. 23, no. 19, pp. 4347–4353, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. K. Oktay, A. P. Cil, and H. Bang, “Efficiency of oocyte cryopreservation: a meta-analysis,” Fertility and Sterility, vol. 86, no. 1, pp. 70–80, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. G. B. La Sala, A. Nicoli, M. T. Villani, M. Pescarini, A. Gallinelli, and I. Blickstein, “Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program,” Fertility and Sterility, vol. 86, no. 5, pp. 1423–1427, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. K. Oktay and G. Karlikaya, “Ovarian function after transplantation of frozen, banked autologous ovarian tissue,” The New England Journal of Medicine, vol. 342, no. 25, p. 1919, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Oktay and E. Buyuk, “Ovarian transplantation in humans: Indications, techniques and the risk of reseeding cancer,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 113, supplement 1, pp. S45–S47, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. P. J. Donnez, M. M. Dolmans, D. Demylle et al., “Livebirth after orthotopic transplantation of cryopreserved ovarian tissue,” The Lancet, vol. 364, no. 9443, pp. 1405–1410, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. D. Meirow, J. Levron, T. Eldar-Geva et al., “Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy,” The New England Journal of Medicine, vol. 353, no. 3, pp. 318–321, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. J. Silber, K. M. Lenahan, D. J. Levine et al., “Ovarian transplantation between monozygotic twins discordant for premature ovarian failure,” The New England Journal of Medicine, vol. 353, no. 1, pp. 58–63, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. Sonmezer, M. I. Shamonki, and K. Oktay, “Ovarian tissue cryopreservation: benefits and risks,” Cell and Tissue Research, vol. 322, no. 1, pp. 125–132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. J. Lee, L. R. Schover, A. H. Partridge et al., “American Society of Clinical Oncology recommendations on fertility preservation in cancer patients,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2917–2931, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. L. Robertson, J. L. Bailey, and M. M. Buhr, “Effects of cold shock and phospholipase A2 on intact boar spermatozoa and sperm head plasma membranes,” Molecular Reproduction and Development, vol. 26, no. 2, pp. 143–149, 1990. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. J. F. Griveau and D. Le Lannou, “Reactive oxygen species and human spermatozoa: physiology and pathology,” International Journal of Andrology, vol. 20, no. 2, pp. 61–69, 1997. View at Google Scholar · View at Scopus
  45. UK Childhood Cancer research Group, “National Registry of Childhood Tumours,” 2004. View at Google Scholar
  46. A. B. Thomson, H. O. D. Critchley, C. J. H. Kelnar, and W. H. B. Wallace, “Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 16, no. 2, pp. 311–334, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. I. Aslam, S. Fishel, H. Moore, K. Dowell, and S. Thornton, “Fertility preservation of boys undergoing anti-cancer therapy: a review of the existing situation and prospects for the future,” Human Reproduction, vol. 15, no. 10, pp. 2154–2159, 2000. View at Google Scholar · View at Scopus
  48. B. Rosenlund, P. Sjoblom, M. Tornblom, C. Hultling, and T. Hillensjo, “In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer,” Human Reproduction, vol. 13, no. 2, pp. 414–418, 1998. View at Google Scholar · View at Scopus
  49. J. U. Schwarzer, K. Fiedler, I. V. Hertwig et al., “Sperm retrieval procedures and intracytoplasmatic spermatozoa injection with epididymal and testicular sperms,” Urologia Internationalis, vol. 70, no. 2, pp. 119–123, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. A. W. Glaser, L. Phelan, M. Crawshaw, S. Jagdev, and J. Hale, “Fertility preservation in adolescent males with cancer in the United Kingdom: a survey of practice,” Archives of Disease in Childhood, vol. 89, no. 8, pp. 736–737, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. S. Elliston, “If you know what's good for you: refusal of consent to medical treatment by children,” in Contemporary Issues in Law, Medicine and Ethics, S. A. M. McLean, Ed., Dartmouth Publications, Aldershot, UK, 1996. View at Google Scholar
  52. S. McLean, “Consent and the law: review of the current provisions in the Human Fertilisation and Embryology Act 1990 for the UK Health Ministers. Consultation document and questionnaire,” Human Reproduction Update, vol. 3, no. 6, pp. 593–621, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Tanner, Foetus into Man: Physical Growth from Conception to Maturity, Castlemead, London, UK, 2nd edition, 1989.
  54. H. Klip, C. W. Burger, P. Kenemans, and F. E. van Leeuwen, “Cancer risk associated with subfertility and ovulation induction: a review,” Cancer Causes and Control, vol. 11, no. 4, pp. 319–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Kashyap and O. K. Davis, “Ovarian cancer and fertility medications: a critical appraisal,” Seminars in Reproductive Medicine, vol. 21, no. 1, pp. 65–71, 2003. View at Google Scholar · View at Scopus
  56. R. H. Carlson, “IVF ovarian stimulation increases risk of borderline ovarian tumors in 15-year follow-up,” Oncology Times, vol. 32, 2009. View at Google Scholar
  57. R. P. Marrs and S. C. Hartz, Comments on the Possible Association between Ovulation Inducing Agents and Ovarian Cancer, The American Fertility Society, Birmingham, UK, 1993.
  58. A. S. Whittemore, M. L. Wu, R. S. Paffenbarger Jr. et al., “Epithelial ovarian cancer and the ability to conceive,” Cancer Research, vol. 49, no. 14, pp. 4047–4052, 1989. View at Google Scholar · View at Scopus
  59. D. J. Joly, A. M. Lilienfeld, E. L. Diamond, and I. D. J. Bross, “An epidemiologic study of the relationship of reproductive experience to cancer of the ovary,” American Journal of Epidemiology, vol. 99, no. 3, pp. 190–209, 1974. View at Google Scholar · View at Scopus
  60. P. C. Nasca, P. Greenwald, and S. Chorost, “An epidemiologic case-control study of ovarian cancer and reproductive factors,” American Journal of Epidemiology, vol. 119, no. 5, pp. 705–713, 1984. View at Google Scholar · View at Scopus
  61. M. L. Wu, A. S. Whittemore, R. S. Paffenbarger Jr. et al., “Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use,” American Journal of Epidemiology, vol. 128, no. 6, pp. 1216–1227, 1988. View at Google Scholar · View at Scopus
  62. B. J. Mosgaard, Ø. Lidegaard, S. K. Kjaer, G. Schou, and A. N. Andersen, “Ovarian stimulation and borderline ovarian tumors: a case-control study,” Fertility and Sterility, vol. 70, no. 6, pp. 1049–1055, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. D. A. Leon, L. M. Carpenter, M. J. M. Broeders, J. Gunnarskog, and M. F. G. Murphy, “Breast cancer in Swedish women before age 50: evidence of a dual effect of completed pregnancy,” Cancer Causes and Control, vol. 6, no. 4, pp. 283–291, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Albrektsen, I. Heuch, and G. Kvale, “The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802 457 parous Norwegian women,” British Journal of Cancer, vol. 72, no. 2, pp. 480–484, 1995. View at Google Scholar · View at Scopus
  65. RCOG Green top Guideline no .12.